LegoChem Biosciences Inc Total Liabilities
LegoChem Biosciences Inc total liabilities. Based on the latest financial reports, LegoChem Biosciences Inc (141080) has total liabilities worth ₩152.41 Billion KRW (≈ $103.29 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 141080 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of LegoChem Biosciences Inc (2014–2025)
Total liabilities of LegoChem Biosciences Inc from 2014 to 2025. This chart illustrates how LegoChem Biosciences Inc's total liabilities have evolved over time, based on quarterly financial data. Explore how much of LegoChem Biosciences Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
LegoChem Biosciences Inc Competitors by Total Liabilities
The table below lists competitors of LegoChem Biosciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Perpetual Ltd
AU:PPT
|
Australia | AU$1.74 Billion |
|
FLEX LNG Ltd
OL:FLNG
|
Norway | Nkr1.87 Billion |
|
Eternal Asia Supply Chain Management Ltd
SHE:002183
|
China | CN¥43.57 Billion |
|
Kelt Exploration Ltd.
TO:KEL
|
Canada | CA$477.39 Million |
|
Lightspeed Commerce Inc
TO:LSPD
|
Canada | CA$173.08 Million |
|
Xiamen Voke Mold & Plastic Engineering Co. Ltd.
SHE:301196
|
China | CN¥1.46 Billion |
|
Guodian Nanjing Automation Co Ltd
SHG:600268
|
China | CN¥6.79 Billion |
|
Amara Raja Batteries Limited
NSE:ARE&M
|
India | Rs33.58 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down LegoChem Biosciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see LegoChem Biosciences Inc asset portfolio.
Liquidity & Leverage Metrics
LegoChem Biosciences Inc Total Liabilities Ratios Explained
LegoChem Biosciences Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LegoChem Biosciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LegoChem Biosciences Inc (2014–2025)
The table below shows the annual total liabilities of LegoChem Biosciences Inc from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩160.69 Billion ≈ $108.90 Million |
+31.30% |
| 2024-12-31 | ₩122.38 Billion ≈ $82.94 Million |
+196.47% |
| 2023-12-31 | ₩41.28 Billion ≈ $27.98 Million |
+25.35% |
| 2022-12-31 | ₩32.93 Billion ≈ $22.32 Million |
-4.43% |
| 2021-12-31 | ₩34.46 Billion ≈ $23.35 Million |
+44.87% |
| 2020-12-31 | ₩23.79 Billion ≈ $16.12 Million |
-14.22% |
| 2019-12-31 | ₩27.73 Billion ≈ $18.79 Million |
+38.49% |
| 2018-12-31 | ₩20.02 Billion ≈ $13.57 Million |
-41.17% |
| 2017-12-31 | ₩34.03 Billion ≈ $23.06 Million |
+15.40% |
| 2016-12-31 | ₩29.49 Billion ≈ $19.99 Million |
+16.74% |
| 2015-12-31 | ₩25.26 Billion ≈ $17.12 Million |
+84.24% |
| 2014-12-31 | ₩13.71 Billion ≈ $9.29 Million |
-- |
About LegoChem Biosciences Inc
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical devic… Read more